<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03511534</url>
  </required_header>
  <id_info>
    <org_study_id>41165</org_study_id>
    <nct_id>NCT03511534</nct_id>
  </id_info>
  <brief_title>Open/Aftercare Treatment for Participants Diagnosed With Obsessive Compulsive Disorder</brief_title>
  <official_title>Open/Aftercare Treatment for Participants Diagnosed With Obsessive Compulsive Disorder</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to provide participants diagnosed with obsessive compulsive
      disorder (OCD) and completed one of the active study protocols at the Rodriguez Lab, with
      open/aftercare treatment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After completing one of the active clinical studies participants have the option to enroll in
      this protocol that offers open treatment.

      The goal is to compare two forms of current standard treatments, psychotherapy vs
      pharmacotherapy.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 23, 2017</start_date>
  <completion_date type="Anticipated">June 2026</completion_date>
  <primary_completion_date type="Anticipated">June 2025</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Participants will choose to enter the psychotherapy or pharmacotherapy arm.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Improvement in the severity of OCD symptoms as measured by the Yale-Brown Obsessive Compulsive Scale (YBOCS)</measure>
    <time_frame>Up to 14 weeks</time_frame>
    <description>Improvement in OCD severity is measured by the YBOCS (Yale Brown Obsessive-Compulsive Scale), a gold standard measure of obsessions and compulsions. For the YBOCS the minimum units are 0 and Maximum units on the total scale are 40. The higher the number on the YBOCS, the more severe the symptoms. Response is defined as at least a 35% reduction on the YBOCS.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>OCD</condition>
  <arm_group>
    <arm_group_label>Psychotherapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will receive evidenced based psychotherapy by a trained psychologist</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pharmacotherapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will receive pharmacotherapy by a psychiatrist</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Psychotherapy</intervention_name>
    <description>Evidenced based psychotherapy by a trained psychologist</description>
    <arm_group_label>Psychotherapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Pharmacotherapy</intervention_name>
    <description>Pharmacotherapy by a psychiatrist</description>
    <arm_group_label>Pharmacotherapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Ability to speak and understand English

          2. Capacity to consent (e.g. as determined by assessing the patient's understanding of
             the risks, benefits, and procedures of the study)

          3. Completed an active study protocol at the Rodriguez Lab at Stanford University

        Exclusion Criteria:

          1. Children younger than 18

          2. Active suicidality
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carolyn Rodriguez, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistant Professor, Stanford University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Andrea Varias, MSHS</last_name>
    <phone>650-723-4095</phone>
    <email>ocdresearch@stanford.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Maria Filippou-Frye, MD, MBS</last_name>
    <phone>650-723-4095</phone>
    <email>mariafilippoufrye@stanford.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Stanford University</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrea Varias, MSHS</last_name>
      <phone>650-723-4095</phone>
      <email>ocdresearch@stanford.edu</email>
    </contact>
    <contact_backup>
      <last_name>Maria Filippou-Frye, MD, MBS</last_name>
      <phone>650-723-4095</phone>
      <email>ocdresearch@stanford.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 18, 2018</study_first_submitted>
  <study_first_submitted_qc>April 18, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 30, 2018</study_first_posted>
  <last_update_submitted>April 27, 2018</last_update_submitted>
  <last_update_submitted_qc>April 27, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 1, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Stanford University</investigator_affiliation>
    <investigator_full_name>Carolyn Rodriguez</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>treatment, psychotherapy, pharmacotherapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Compulsive Personality Disorder</mesh_term>
    <mesh_term>Obsessive-Compulsive Disorder</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

